Bharat Immunologicals & Biologicals Corporation

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue26.800.108.140.100.16
Expenses30.766.4313.826.076.81
EBITDA-2.18-4.62-3.53-4.22-4.53
EBIT-2.22-4.66-3.62-4.25-4.56
Profit Before Tax-3.96-6.33-5.68-5.97-6.65
Net Profit-3.08-4.68-3.88-4.59-4.92
Financial Ratios
Operating Profit Margin-8.23%0.00%-46.14%0.00%0.00%
Net Profit Margin-11.63%0.00%-50.72%0.00%0.00%
Earning Per Share (Diluted)-0.71-1.08-0.90-1.06-1.14
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ